Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancer

This study has been completed.
Information provided by (Responsible Party):
Merck KGaA Identifier:
First received: June 9, 2005
Last updated: February 17, 2014
Last verified: February 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2007
  Primary Completion Date: May 2006 (Final data collection date for primary outcome measure)